News

Sort by Latest
The Pharmaceutical Intellectual Property and Competition Law Review
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview...
September 16, 2022
1 min read
China’s First Supreme Court Patent Linkage Decision
On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on...
September 7, 2022
11 min read
Italy: Pharmaceutical company fined by the Italian Competition Authority for the sale of a lifesaving drug at excessive prices
Essetifin S.p.A., Leadiant Biosciences Ltd., Leadiant GmbH and Sigma – Tau Arzenmittel GmbH (“Leadiant”)...
July 18, 2022
6 min read
Final(ly) Rules of Procedure of the UPC
Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations,...
July 18, 2022
1 min read
Spanish Competition Authority analyses distribution of medicines in Spain
On June 22, 2022, the Spanish Competition Authority (“CNMC”) published a study about the wholesale...
July 18, 2022
6 min read
To opt-out or not? The UPC will change the rules of the game in the European patent field possibly as soon as next fall
Early this year it became clear that the long-pending reform of the European patent system is finally...
June 1, 2022
7 min read
Artificial Intelligence Systems for Medical Diagnosis
The Italian Ministry of Health has published a document on its website entitled “Artificial Intelligence...
May 25, 2022
1 min read
China Health and Medical Data Protection (I): Human Genetic Resources Information
I. An Overview of Regulatory Regime Under the Chinese law, human generic resources...
May 24, 2022
13 min read
New Draft Implementing Regulations propose key changes for pharmaceuticals in China
On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations...
May 19, 2022
5 min read